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ABSTRACT: Burkholderia pseudomallei is the bacterium responsible for
melioidosis, an infectious disease with high mortality rates. Since
melioidosis is a signi!cant public health concern in endemic regions
and the organism is currently classi!ed as a potential biothreat agent, the
development of e"ective vaccines and rapid diagnostics is a priority. The
capsular polysaccharide (CPS) expressed by B. pseudomallei is a highly
conserved virulence factor and a protective antigen. Because of this, CPS
is considered an attractive antigen for use in the development of both
vaccines and diagnostics. In the present study, we describe the
interactions of CPS with the murine monoclonal antibody (mAb) 4C4
using a multidisciplinary approach including organic synthesis, molecular biology techniques, surface plasmon resonance, and
nuclear magnetic spectroscopy. Using these methods, we determined the mode of binding between mAb 4C4 and native CPS or
ad hoc synthesized capsular polysaccharide fragments. Interestingly, we demonstrated that the O-acetyl moiety of CPS is essential
for the interaction of the CPS epitope with mAb 4C4. Collectively, our results provide important insights into the structural
features of B. pseudomallei CPS that enable antibody recognition that may help the rational design of CPS-based vaccine
candidates. In addition, our !ndings con!rm that the mAb 4C4 is suitable for use in an antibody-based detection assay for
diagnosis of B. pseudomallei infections.
Burkholderia pseudomallei, the etiologic agent of melioidosis, is a
facultative intracellular, Gram-negative pathogen that causes
severe, debilitating, and often fatal diseases in humans and
animals.1 This environmental saprophyte can be isolated from
moist soils, stagnant waters, and rice paddies in endemic
regions that typically border 20° north and south of the
equator.2,3 Routes of infection include inhalation, ingestion, and
percutaneous inoculation.4 Clinical symptoms of melioidosis
are multifaceted, and disease may manifest as chronic or acute
localized infections, acute pulmonary infections, or fulminating
septicemias.1,3 Treatment of these diseases can be challenging,
and even with appropriate antibiotic therapy, mortality rates are
unacceptably high.5,6 At present, there are no human or
veterinary vaccines available for immunization against melioi-
dosis. Due to the potential misuse of B. pseudomallei as an agent
of biological warfare and terrorism, as well as its impact on
public health in endemic regions, there is a signi!cant interest
in developing e"ective vaccines and rapid diagnostics to combat
disease caused by this CDC (Centers for Disease Control and
Prevention) Tier 1 select agent.7,8
Capsular polysaccharides (CPS) are a major component of
bacterial cell envelopes. Structurally diverse in nature, these
highly hydrated antigens exhibit a variety of important
biological functions including resistance to desiccation,
adherence to host tissues, and protection against innate/
acquired immune defenses.9 Previous studies have demon-
strated that the predominant CPS antigen expressed by B.
pseudomallei is an unbranched homopolymer consisting of
monosaccharide repeats having the structure [!3)-2-O-acetyl-
6-deoxy-!-D-manno-heptopyranose-(1!].10 Interestingly, sim-
ilar to Burkholderia mallei, all virulent isolates of B. pseudomallei
express this CPS antigen.11
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Several studies have shown that CPS-de!cient mutants of B.
pseudomallei are avirulent in small animal models of
infection.12"14 It has also been shown that CPS production
by B. pseudomallei contributes to resistance to phagocytosis by
reducing C3b deposition on the surface of the bacterium, again
implicating CPS as an important virulence determinant.13,15,16
More recently, it has been shown that CPS-speci!c mouse
monoclonal antibodies (mAbs) and CPS-based glycoconjugates
are capable of passively/actively immunizing mice against lethal
challenges of B. pseudomallei.17"19 Such !ndings con!rm the
protective capacity of this surface-exposed antigen and support
the rationale for exploring the use of CPS-based vaccines and
CPS-speci!c mAbs to prevent/treat melioidosis. In addition,
during active infections, CPS has been identi!ed as a circulating
bacterial antigen that represents an attractive diagnostic target
for melioidosis.20 The purpose of our study was to investigate,
at a molecular level, the interaction between a speci!c murine
monoclonal antibody, mAb 4C4, and the CPS from B.
pseudomallei in order to support their therapeutic and
diagnostic potential against melioidosis. To accomplish this,
we employed a multidisciplinary approach including organic
synthesis, molecular biology techniques, and biophysical
methods. The isolation and puri!cation of both the murine
monoclonal antibody and B. pseudomallei CPS allowed the use
of SPR (surface plasmon resonance) and NMR (nuclear
magnetic resonance) techniques to gain insights into the mAb
4C4 a#nity for CPS, as well as on the structural requirements
for epitope binding. Furthermore, ad hoc synthesized fragments
of CPS were used to investigate in depth the structural features
of the interaction with the mAb 4C4, with the aim to provide a
detailed picture of the pathogen recognition process in solution.
! RESULTS AND DISCUSSION
Binding of CPS to mAb 4C4. Immunoblot Analyses. The
!rst evidence we gained on the binding between the CPS from
B. pseudomallei and mAb 4C4 derived from immunoblot
analyses (see Supporting Information). In order to demonstrate
that the monoclonal antibody was able to recognize the
pathogen capsular polysaccharide, we !rst carried out a dot blot
experiment. Once spotted onto the nitrocellulose !lter, the
puri!ed CPS and the lipopolysaccharide (LPS) from E. coli
chosen as a reference, we incubated it with the mAb 4C4. As
expected, data showed that CPS was reactive with the
monoclonal antibody, unlike the LPS from E. coli (Figure
S1). These results were then con!rmed by a Western blot
analysis performed on the native capsule, the deacetylated CPS,
and the LPS from B. pseudomallei. All the samples were probed
with mAb 4C4 (Figure S1), and the results suggested that there
was an interaction only between the monoclonal antibody and
the native CPS, while neither the deacetylated CPS nor the LPS
were recognized by the mAb 4C4.
NMR Analysis. The system CPS"mAb 4C4 also underwent
NMR analysis, speci!cally by Saturation Transfer Di"erence
(STD) NMR spectroscopy,21,22 with the aim of identifying the
region of the polysaccharide closer to the mAb binding pocket.
First attempts to investigate the ligand"antibody interaction by
STD NMR spectroscopy were unsuccessful. In fact, despite the
use of di"erent irradiation frequencies, the capsule, even in the
absence of the antibody, became inherently saturated and thus
gave rise to signals in the STD NMR spectra, due to its high
molecular weight. Accordingly, we decided to carry out STDD
(saturation transfer double di"erence) NMR experiments23
with the aim to qualitatively assess the occurrence of binding
between the antibody and the CPS. In detail, we performed a
reference STD NMR spectrum of the capsule in the absence of
the antibody, and then we subtracted the resulting STD
spectrum from that of CPS in the presence of the mAb 4C4
(Figures S2,S3). The observed signals in the STDD spectrum
were further proof of the binding between the antibody and the
capsular polysaccharide (Figure S2), in accordance with the
immunoblot analyses.
SPR Analysis. The binding of mAb 4C4 to CPS was also
investigated using SPR, which is a method that allows for
analysis of bimolecular interactions in real-time and without
chemical reporters. Biotin-labeled CPS was immobilized on the
surface of a streptavidin-coated sensor chip, after which the
binding of several serial dilutions (330"1.3 nM) of mAb 4C4
was analyzed. Each concentration of mAb was injected over the
sensor surface for 60 s, after which it was allowed to passively
dissociate for 120 s.
The association (0"60 s) and dissociation (60"180 s)
phases of mAb 4C4 at each concentration were recorded and
plotted as a sensorgram, which shows the changes in refractive
index (binding/dissociation) in arbitrary response units (RU)
as a function of time (s) (Figure 1, colored lines). The
sensorgrams that were produced by each concentration of mAb
4C4 appeared to show biphasic kinetics!both kon and koff were
composed of a “fast” phase and “slow” phase. This kinetic
model is expected to be complex due to the multivalency of the
CPS antigen and the bivalency of mAb 4C4. A bivalent analyte
kinetic algorithm was used to !t the binding data and
determined the apparent kinetic constants (Figure 1, black
lines): kon = 1.2 ! 106 M"1 s"1, koff = 0.035 s"1.
Binding of ad hoc Synthesized CPS Fragments (1"3) to
mAb 4C4. In order to acquire further information on the
binding mode of the mAb 4C4 and to accurately map the
interacting epitope, synthetic fragments (monosaccharide 1,
disaccharide 2, and deacetylated disaccharide 3) related to the
CPS of B. pseudomallei were investigated.
As depicted in Scheme 1, the target compounds 1 and 2 were
synthesized from a thioheptoside donor according to a
sequence involving a !-stereoselective naphthyl-mediated
intramolecular aglycon delivery (NAP-IAD) followed by C2-
acetylation and global deprotection.24 Ammonolysis of
Figure 1. SPR analysis of mAb 4C4 binding to CPS. Biotinylated CPS
was immobilized on the surface of a streptavidin-coated sensor chip.
Samples (2-fold serial dilution of mAb 4C4 [330"1.3 nM]) were
injected over the sensor surface for 60 s, after which the mAb was
allowed to passively dissociate for 120 s. Apparent kinetic kon and koff
values were determined using a bivalent analyte kinetic algorithm.
Both the experimental (colored lines) and !tted (black lines) data are
shown.
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disaccharide 2 led to the formation of the deacetylated
disaccharide 3, which was also investigated for binding with
mAb 4C4.
STD NMR Analysis. As a !rst step of the analysis, STD NMR
experiments were performed on both acetylated ligands (1 and
2) in the presence of the antibody, once the experimental
conditions optimized. The STD NMR spectrum obtained on
the monosaccharide 1-mAb 4C4 mixture did not show any
signal (Figure S4), likely due to unfavorable binding kinetics,
which impaired an e#cient NOE buildup and the observation
of STD-NMR e"ects.25,26
Interesting results were achieved by the analysis of the
interaction between the antibody and synthetic disaccharide 2,
which allowed the direct characterization of the ligand binding
epitope (Figure 2). A qualitative evaluation of the STD e"ects
for the sugar proton signals showed that the strongest
enhancement was observed for the O-acetyl group located at
C2, indicating that the OAc moiety was in close contact with
the antibody, experiencing the highest transfer of saturation.
These data were in accordance with the above results obtained
for the binding of mAb to the native capsule (Figures S1,S2).
Furthermore, STD e"ects were also observed for proton signals
at positions 7, 5, 4, and 6; on the other hand, proton signals 1,
2, and 3 were not boosted, emphasizing their distance from the
antibody surface binding site.
In order to quantitatively investigate the CPS recognition
from the antibody mAb 4C4, STD buildup curves were
determined at di"erent saturation times.27,28 This method
allowed minimization of possible bias in the calculation of STD
e"ects due to the di"erent proton longitudinal relaxation times
(T1), as well as the intramolecular spin di"usion within the
bound state (see Supporting Information, Figure S5).
Table 1 summarizes the STD percentages (STD epitope !t)
derived from the !tting of experimental data to the
monoexponential equation STD = STDmax[1 " exp("ksatt)].
From the quantitative results, it was con!rmed that the
protons H7, H5, H4, and H6 were recognized by the antibody
since they exhibited an STD epitopefit above the 70%.
Particularly, the epitope map of disaccharide 2 showed also
that the highest degree of enhancement was ascribable to the
acetyl moiety of the 6-deoxyheptose. These outcomes were in
agreement with Western blotting data which assessed the loss
of reactivity of the deacetylated CPS with mAb 4C4 (Figure
S1), con!rming the importance of the acetyl group for the
interaction with the antibody.
Given the previous results and in order to understand if the
acetyl group was strictly required for the recognition event, we
chose to investigate, by STD NMR, the interaction between the
deacetylated disaccharide 3 and mAb 4C4 (Figure 3). It is
noteworthy that no STD NMR signal was observed from the
whole disaccharide, indicating that the acetyl moiety was
de!nitely essential for the recognition and binding of the CPS
epitope with the antibody. We could then conclude that the
binding was deeply hampered by the absence of this ligand
portion.
Tr-NOE Analysis. The transferred NOE method allows
acquisition of key information about the bioactive conformation
of a ligand bound to its receptor; therefore, it represents a
suitable approach to complement interaction studies gained by
STD NMR spectroscopy. In order to assess the ability of mAb
4C4 to recognize the disaccharide 2 and to analyze its possible
conformational changes upon binding, we carried out 2D
NOESY experiments on the ligand in the presence and in the
absence of the monoclonal antibody. As shown in Figure 4, the
change in the sign of NOE signals, between the free ligand and
the bound form in solution, con!rmed the physical binding
between mAb 4C4 and disaccharide 2.29
A quantitative analysis based on the construction of NOE
buildup curves30,31 was performed, and the consequent
evaluation of the pattern of speci!c interglycosydic NOE
contacts allowed the description of the mAb binding mode.
The cross peak intensity, measured at di"erent mixing times,
was used to extract the 1H"1H cross relaxation rate (") and to
calculate the proton"proton inter-residual distances. These
values were then compared with the calculated distances
obtained for the main energetic minimum, predicted for the
disaccharide 2 (Figure 5a,b).
Although slight di"erences in the cross peak volumes were
observed between the free and the bound state, the quantitative
results indicated that the glycosydic linkage, and thus the
disaccharide whole conformation, was barely a"ected upon
binding to the antibody. The comparison of the experimental
Scheme 1. Synthetic Mono- and Disaccharidic Fragments
(1"3) of CPS from B. pseudomallei (Ac = acetyl; All = allyl;
Bn = benzyl; IAD = intramolecular aglycon delivery; NAP =
2-naphthylmethyl; SPh = thiophenyl)
Figure 2. STD NMR analysis of disaccharide 2 when bound to mAb
4C4. (a) Reference 1H NMR spectrum and (b) STD 1D NMR
spectrum of a 1:60 mAb 4C4/disaccharide 2 mixture. (c) Chemical
structure and epitope binding of disaccharide 2 bound to mAb 4C4.
The irradiation frequency was set at "1 ppm, and a saturation time of
2 s was used. The sugar protons more involved in the interaction are
indicated with the following color coding. Red circle: STD 100%.
Orange circle: STD 90"70%. Yellow circle STD < 70%.
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and calculated distances (Table S1), indeed, demonstrated that,
both in the free and bound state, the disaccharide preferentially
populates the energetic minimum characterized by positive
values of the dihedral angles, # (#50°) and $ (#10°) (Figure
5c).
Pulsed-!eld Gradient (PFG)-NMR Analysis. An alternative
approach, based on PFG NMR measurements, was employed
for studying the recognition of B. pseudomallei by the
monoclonal antibody mAb 4C4. PFG-NMR is a useful
technique to calculate the di"usion coe#cient (D) of molecules
in solution and o"ers a fast method to characterize molecular
interactions.32 A ligand and its receptor exhibit, in the free state,
their own di"usion coe#cients, which are dependent on their
weight, size, and shape. When the ligand forms a complex with
its receptor protein, a variation in the observed D may occur. In
detail, for the case where the host"guest association is strong,
both the ligand and the protein exhibit the same di"usion
coe#cient that re$ects the tight complex. In the case of weak
interaction, no changes in D values are observed; for the other
cases, when exchange is fast on the NMR time scale, the
measured di"usion coe#cient is the weighted average of that of
the free and bound ligand.33,34 The possibility to discriminate
between the di"usion coe#cient of the disaccharide 2 and
those of the antibody mAb 4C4 (see Supporting Information,
Figures S6"S7) simpli!ed the attempt to investigate the
binding by using PFG NMR experiments.35 In order to achieve
the condition of fast exchange, on both chemical shift and
di"usion time scales, a molar excess of ligand and su#ciently
long values of % were used (see Methods).32 Self-di"usion
coe#cients of the free and the bound forms were determined
by following the decay of signal intensity at 2.18 ppm of the
acetyl group (Figure 6). The quantitative analysis of the PFG
NMR spectra yielded a di"usion coe#cient of 5.2 ! 10"10 m2/s
for the disaccharide 2 alone in solution, while, upon the
addition of the mAb, it skewed toward lower values (3.9 !
10"10 m2/s). Therefore, as we expected, going from the free to
the bound form, the ligand showed a change in the measured
di"usion coe#cient, further highlighting the recognition of
disaccharide 2 by the antibody.
The resulting di"usion coe#cients are reported at the top
right of each panel. The error associated with the measurement
was estimated, from repeated calculations of the di"usion
coe#cients, to be below 5%. Notably, monoexponential
behavior was observed also for the decay of other proton
signals (data not shown).
Conclusions. Understanding how complex glycans interact
with antibodies constitutes a pivotal step toward the design of
new carbohydrate-based vaccines or drugs against several
diseases and bacterial infections. Currently, disparate poly-
saccharide derived vaccines, which are able to boost the
immune response against carbohydrates exposed on disease-
causing bacteria, are commercially available.37"39 On the other
hand, the conjugation of appropriate oligosaccharide to a carrier
protein, as well as the use of glycan mimetics to replace or
complement them in the triggering of immune response,
represents di"erent valuable strategies.40 In recent years, several
studies based on NMR, molecular modeling, and X-ray analysis
were published to promote the development of e#cient vaccine
strategies against pathogens like Shigella f lexneri,39"41 for
instance. NMR spectroscopic methods, coupled to X-ray
crystallography, indeed constitute an exquisite tool to gain
molecular level insight into the antibody recognition of
bacterial surface glycoconjugates required to design e#cient
carbohydrate-based vaccines or drugs.42 To date, only a small
number of mAb-glycoconjugate X-ray structures were re-
ported.43 Thus, whenever the production of complexes for
crystallographic studies is not achieved,42 NMR represents a
robust approach to improve the knowledge on the mechanisms
Table 1. Experimental STD Intensities of Disaccharide 2 Bound to mAb 4C4 at Di!erent Saturation Timesa
STD exp
1H 1s 3s 5s STD max Ksat STD (!t) STD epitope (!t)
H7 77.2 67.2 57.3 0.0094 0.4586 0.00431 84
H4 90.9 89 80 0.0147 0.3191 0.00469 91.4
H5 90.9 89 80 0.0147 0.3191 0.00469 91.4
H6 68.1 63.6 53.3 0.0091 0.4134 0.00376 73.2
OAc 100 100 100 0.0197 0.2607 0.00513 100
aSTDmax were calculated by !tting the data to a monoexponential equation: STD(tsat) = STDmax(1 " exp("ksat ! tsat)).
Figure 3. STD NMR analysis of disaccharide 3 when bound to mAb
4C4. (a) Reference 1H NMR spectrum and (b) STD 1D NMR
spectrum of a 1:100 mAb 4C4/deacetylated disaccharide mixture. (c)
Chemical structure of the deacetylated disaccharide.
Figure 4. NOESY spectra of the disaccharide 2. On the left: NOESY
of the disaccharide 2 in the free state. On the right: tr-NOESY of the
disaccharide 2 bound to mAb 4C4. A mixing time of 300 ms was used.
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of glycoconjugates recognition by antibodies. Moreover,
peptides or glycopeptides that mimic complex bacterial
polysaccharide antigens, derived from NMR based analysis,
represent alternatives to the classical polysaccharide-based
conjugate vaccines developed so far. To this aim, the analysis
of the molecular basis of bacterial antigens"antibody
recognition and binding constitutes a breakthrough in the
development of new conjugate vaccines; the map of the binding
epitope, in fact, is a starting point to design peptides or
glycopeptides mimicking the binding antigen.
In this context, the present study focused on the application
of NMR methods to investigate the key structural requisites
governing the recognition of B. pseudomallei surface glycans by
the murine monoclonal antibody 4C4. In this work, we
employed a multidisciplinary approach including organic
synthesis, molecular biology, and biophysics. Upon the isolation
and puri!cation of the CPS from B. pseudomallei and the
monoclonal antibody mAb 4C4, we gained the !rst evidence of
binding from immunoblotting experiments. Then, an accurate
NMR analysis, carried out on both puri!ed and ad hoc
synthesized products, permitted the in depth characterization of
the binding at the atomic level. Interestingly, STD NMR
experiments demonstrated that the acetyl group, located at
position 2 of the B. pseudomallei CPS repeating unit, played an
essential role in the interaction with the antibody surface. Its
e"ect on the recognition event was so signi!cant that the
absence of the acetyl moiety resulted in a complete loss of mAb
4C4 a#nity for the pathogen. Furthermore, transferred NOESY
methods have been employed to improve the knowledge on the
conformational behavior of the bacterial CPS. In the case of
mAb 4C4"CPS disaccharide fragment recognition, no
conformational selection occurred upon binding, unlike some
previously described protein"carbohydrate interaction sys-
tems.29
All these outcomes may have implications in the develop-
ment of new therapeutics and diagnostics against melioidosis.
Indeed, on the one side, our results support the potential use of
the mAb 4C4 as an adjunct therapy to antibiotics and, at the
same time, indicate that the acetyl moiety is strictly required for
optimal mimicry of the CPS epitope. These !ndings are of
particular note in the context of vaccine and therapeutic design
because the !ne-tuning of selective binders resides at the basis
of highly active drugs production.44
On the other hand, our data provide a rational basis to
improve the early detection of the pathogen B. pseudomallei and
support the CPS as a potential biomarker for diagnosis of
melioidosis. Along with being secreted during infection, the
CPS appears to be present in most all B. pseudomallei and B.
mallei isolates and rarely found in near neighbor Burkholderia
species.20 This has recently been shown by analytical reactivity
and speci!city testing with the CPS-speci!c mAb 3C5.45 The
collected data, indeed, underline the utility of including mAb
4C4 in a point of care microbial detection assay. In fact, due to
its superior a#nity for CPS, mAb 4C4 has replaced mAb 3C5
Figure 5. Tr-NOESY analysis. (a) Adiabatic energy map of disaccharide 2 indicating one main global minimum characterized from # and $ positive
values (Min I). (b) In the upper panel, NOE buildup curves of disaccharide 2, for A3-B1 and A2-B1 contacts, in the absence of mAb 4C4. In the
lower panel, the buildup curves of the disaccharide 2, for the same cross peaks, in the presence of the antibody. The curves have been normalized
using the decay of the corresponding diagonal signal as a reference. (c) Representations of the predicted energetic minimum, preferentially populated
by the ligand in the free and bound state. STD derived epitope mapping on the molecular envelope of disaccharide 2, with color coding from the
highest (red) to the lowest (yellow) observed STD e"ect (cf. Table 1, Figure 2).
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in the prototype Active Melioidosis Detect Lateral Flow
Immunoassay (AMD LFI)45 In unpublished studies, mAb
4C4 appears to possess similar analytical reactivity and
speci!city to that of mAb 3C5, while its superior a#nity
might allow for detection of lower concentrations of CPS
within patient samples.
To conclude, the comprehension, at a molecular level, of
which structural and conformational elements of the CPS
in$uenced the selectively binding with mAb 4C4, may open a
new avenue toward establishing rules for the focused design of
carbohydrate-based antigens, diagnostics, and therapeutics
against melioidosis; performing passive immunization studies
with these CPS speci!c mAbs may validate the usefulness of a
CPS-based vaccine and o"er insights as to the a#nity and IgG
subclass that may need to be generated with such a vaccine.
! METHODS
Puri!cation of B. pseudomallei CPS and LPS. Puri!ed
CPS and LPS antigens were obtained as previously
described46,47 from B. pseudomallei RR2683 (O-polysaccharide
mutant) and B. pseudomallei RR2808 (CPS mutant; see also the
Supporting Information).
Immunization of Mice and Production of mAb 4C4.
mAb 4C4 IgG1 was produced as described in the Supporting
Information.
SDS-PAGE, Dot Blot, Western Immunoblotting Anal-
yses. See the Supporting Information.
SPR. Antibody"antigen binding experiments were per-
formed as previously described.48 The experimental details
are reported in the Supporting Information.
NMR Analysis. All NMR experiments were performed with
a Bruker 600 MHz DRX instrument !tted with a cryo probe at
310 K. All the samples were dissolved in a phosphate bu"er
(pH 7.4), and spectra were calibrated with internal sodium
[d4](trimethylsilyl)propionate (TSP).
Data acquisition and processing were performed with
TOPSPIN 3.2 software.
The experimental conditions used in STD NMR, STDD
NMR, tr-NOESY, and PFG-NMR analyses are described in
detail in the Supporting Information.
Conformational Studies. Molecular mechanics calcula-




The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acschem-
bio.5b00502.
Reactivity of mAb 4C4 with CPS antigens (Figure S1),
STDD NMR analysis of the binding between mAb 4C4
and the CPS (Figure S2), control NMR spectra for
STDD analysis (Figure S3), STD NMR analysis of the
binding between mAb 4C4 and the monosaccharide 1
(Figure S4), STD buildup curves for protons of
disaccharide 2 in the presence of mAb 4C4 (Figure
S5), experimental and calculated interproton distances
for the disaccharide 2 (Table S1), PFG NMR analysis of
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